AFAP1 and breast carcinoma: The bioinformatics tool “GEPIA” was applied to analyze 1085 patients with breast cancer and 291 normal tissues, indicating that the AFAP1‐AS1 expression in breast cancer tissue was significantly increased compared to adjacent normal tissue, as determined by Transcripts Per Million (TPM) (Figure 2C).